Versiti - Richard H. Aster, MD | Versiti Blood Research Institute
Careers News
Richard H.

Aster, MD

Senior Investigator Emeritus

Transfusion Medicine, Vacular Biology & Cellular Therapy

Senior Investigator Emeritus

Education and training

Postdoctoral Training
University of Michigan
Massachusetts General Hospital
National Institutes of Health
Thorndike Laboratory, Harvard Medical School

Doctoral Training
MD, University of Michigan, 1957

Research Interests

Transfusion Medicine

Blood cells are targeted for destruction by antibodies in many clinically important disorders. Some of these conditions have an autoimmune etiology; others are caused by alloantibodies, isoantibodies or drug sensitivity. We engaged in studies to improve the understanding of this family of disorders.

Selected Publications

Patents

  • Method of detecting heparin-induced thrombocytopenia. US Patent 5,972,718 Issued October 26, 1999
  • Method and kit for detecting heparin-induced thrombocytopenia. US Patent 5,972,717 Issued October 26, 1999
  • Nucleic acids for the detection of the Bak polymorphism in human platelet membrane glycoprotein IIb US Patent 5,652,357 Issued July 19, 1997
  • Polymorphism of human platelet membrane glycoprotein IIIa and diagnostic and therapeutic applications thereof 5,091,302 Issued February 25, 1992; US Patent 5,391,714 Patent Issued February 21, 1995; US Patent 5,670,337 Issued September 23, 1997; Japanese Patent 3,221,679 Issued August 17, 2001
  • A method of detecting platelet-activating antibodies in patients suspected of having heparin-induced thrombocytopenia. Patent 14/437,066 issued December 26, 2017